Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$145.61 USD
+1.83 (1.27%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $145.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 0.00 |
EPS Last Quarter | 0.73 |
Last EPS Surprise | 763.64% |
ABR | 1.47 |
Earnings ESP
|
15,650.24% |
---|---|
Current Year | 3.76 |
Next Year | 9.25 |
EPS (TTM) | 0.47 |
P/E (F1) | 38.68 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 398.33M | 534.04M | 2.06B | 3.21B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 463.00M | 632.00M | 2.43B | 4.10B |
Low Estimate | 365.60M | 454.60M | 1.87B | 2.71B |
Year ago Sales | 261.24M | 331.82M | 1.24B | 2.06B |
Year over Year Growth Est. | 52.48% | 60.94% | 65.97% | 55.78% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.00 | 1.00 | 3.76 | 9.25 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | -0.06 | 0.46 | 1.77 | 5.79 |
High Estimate | 0.45 | 1.92 | 7.65 | 13.58 |
Low Estimate | -0.12 | 0.46 | 1.77 | 5.55 |
Year ago EPS | -0.27 | -0.46 | -5.80 | 3.76 |
Year over Year Growth Est. | 100.00% | 317.39% | 164.83% | 145.93% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 2 | 4 | 5 |
Up Last 60 Days | 0 | 2 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.00 | 1.00 | 3.76 | 9.25 |
7 Days Ago | 0.00 | 1.00 | 3.76 | 9.25 |
30 Days Ago | -0.07 | 1.16 | 2.93 | 7.95 |
60 Days Ago | -0.05 | 0.88 | 2.46 | 6.67 |
90 Days Ago | -0.02 | 0.91 | 2.18 | 6.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.45 | 1.02 | 3.93 | 9.24 |
Zacks Consensus Estimate | 0.00 | 1.00 | 3.76 | 9.25 |
Earnings ESP | 15,650.24% | 2.41% | 4.36% | -0.12% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.73 | 0.47 | -0.46 | -0.27 | NA |
Estimate | -0.11 | -0.03 | -1.66 | -1.89 | NA |
Difference | 0.84 | 0.50 | 1.20 | 1.62 | 1.04 |
Surprise | 763.64% | 1,666.67% | 72.29% | 85.71% | 647.08% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more